OBJECTIVE: Genetic modulation of heart function is a novel therapeutic strategy. We investigated the effect of molecular cardiac surgery with recirculating delivery (MCARD)-mediated carboxyl-terminus of the β-adrenergic receptor kinase (βARKct) gene transfer on cardiac mechanoenergetics and β-adrenoreceptor (βAR) signaling. METHODS: After baseline measurements, sheep underwent MCARD-mediated delivery of 10(14) genome copies of self-complimentary adeno-associated virus (scAAV6)-βARKct. Four and 8 weeks after MCARD, mechanoenergetic studies using magnetic resonance imaging were performed. Tissues were analyzed with real-time quantitative polymerase chain reaction (RT-qPCR) and Western blotting. βAR density, cyclic adenosine monophosphate levels, and physiologic parameters were evaluated. RESULTS: There was a significant increase in dP/dt(max) at 4 weeks: 1384 ± 76 versus 1772 ± 182 mm Hg/s; and the increase persisted at 8 weeks in response to isoproterenol (P < .05). Similarly, the magnitude of dP/dt(min) increased at both 4 weeks and 8 weeks with isoproterenol stimulation (P < .05). At 8 weeks, potential energy was conserved, whereas in controls there was a decrease in potential energy (P < .05) in response to isoproterenol. RT-qPCR confirmed robustness of βARKct expression throughout the left ventricle and undetectable expression in extracardiac tissues. Quantitative Western blot data confirmed higher expression of βARKct in the left ventricle: 0.46 ± 0.05 versus 0.00 in lung and liver (P < .05). Survival was 100% and laboratory parameters of major organ function were within normal limits. CONCLUSIONS: MCARD-mediated βARKct delivery is safe, results in robust cardiac-specific gene expression, enhances cardiac contractility and lusitropy, increases adrenergic reserve, and improves energy utilization efficiency in a preclinical large animal model. Copyright Â
OBJECTIVE: Genetic modulation of heart function is a novel therapeutic strategy. We investigated the effect of molecular cardiac surgery with recirculating delivery (MCARD)-mediated carboxyl-terminus of the β-adrenergic receptor kinase (βARKct) gene transfer on cardiac mechanoenergetics and β-adrenoreceptor (βAR) signaling. METHODS: After baseline measurements, sheep underwent MCARD-mediated delivery of 10(14) genome copies of self-complimentary adeno-associated virus (scAAV6)-βARKct. Four and 8 weeks after MCARD, mechanoenergetic studies using magnetic resonance imaging were performed. Tissues were analyzed with real-time quantitative polymerase chain reaction (RT-qPCR) and Western blotting. βAR density, cyclic adenosine monophosphate levels, and physiologic parameters were evaluated. RESULTS: There was a significant increase in dP/dt(max) at 4 weeks: 1384 ± 76 versus 1772 ± 182 mm Hg/s; and the increase persisted at 8 weeks in response to isoproterenol (P < .05). Similarly, the magnitude of dP/dt(min) increased at both 4 weeks and 8 weeks with isoproterenol stimulation (P < .05). At 8 weeks, potential energy was conserved, whereas in controls there was a decrease in potential energy (P < .05) in response to isoproterenol. RT-qPCR confirmed robustness of βARKct expression throughout the left ventricle and undetectable expression in extracardiac tissues. Quantitative Western blot data confirmed higher expression of βARKct in the left ventricle: 0.46 ± 0.05 versus 0.00 in lung and liver (P < .05). Survival was 100% and laboratory parameters of major organ function were within normal limits. CONCLUSIONS: MCARD-mediated βARKct delivery is safe, results in robust cardiac-specific gene expression, enhances cardiac contractility and lusitropy, increases adrenergic reserve, and improves energy utilization efficiency in a preclinical large animal model. Copyright Â
Authors: Titus Kuehne; Sevim Yilmaz; Paul Steendijk; Phillip Moore; Maarten Groenink; Maythem Saaed; Oliver Weber; Charles B Higgins; Peter Ewert; Eckard Fleck; Eike Nagel; Ingram Schulze-Neick; Peter Lange Journal: Circulation Date: 2004-09-27 Impact factor: 29.690
Authors: J D White; D M Thesier; J B D Swain; M G Katz; C Tomasulo; A Henderson; L Wang; C Yarnall; A Fargnoli; M Sumaroka; A Isidro; M Petrov; D Holt; R Nolen-Walston; W J Koch; H H Stedman; J Rabinowitz; C R Bridges Journal: Gene Ther Date: 2011-01-13 Impact factor: 5.250
Authors: Sitaram M Emani; Ashish S Shah; Michael K Bowman; David C White; Sitaramesh Emani; Donald D Glower; Walter J Koch Journal: J Thorac Cardiovasc Surg Date: 2004-03 Impact factor: 5.209
Authors: Danny Chu; Christopher C Sullivan; Matthew D Weitzman; Lingling Du; Paul L Wolf; Stuart W Jamieson; Patricia A Thistlethwaite Journal: J Thorac Cardiovasc Surg Date: 2003-09 Impact factor: 5.209
Authors: Alice F Tarantal; C Chang I Lee; Michele L Martinez; Aravind Asokan; R Jude Samulski Journal: Hum Gene Ther Date: 2017-01-25 Impact factor: 5.695
Authors: Stephen C Kolwicz; Guy L Odom; Sarah G Nowakowski; Farid Moussavi-Harami; Xiaolan Chen; Hans Reinecke; Stephen D Hauschka; Charles E Murry; Gregory G Mahairas; Michael Regnier Journal: Mol Ther Date: 2015-09-21 Impact factor: 11.454
Authors: JaBaris D Swain; Anthony S Fargnoli; Michael G Katz; Catherine E Tomasulo; Marina Sumaroka; Kyle C Richardville; Walter J Koch; Joseph E Rabinowitz; Charles R Bridges Journal: J Cardiovasc Transl Res Date: 2012-12-01 Impact factor: 4.132
Authors: Anthony S Fargnoli; Michael G Katz; Charles Yarnall; Alice Isidro; Michael Petrov; Nury Steuerwald; Sriparna Ghosh; Kyle C Richardville; Richard Hillesheim; Richard D Williams; Erik Kohlbrenner; Hansell H Stedman; Roger J Hajjar; Charles R Bridges Journal: Ann Thorac Surg Date: 2013-06-15 Impact factor: 4.330
Authors: Michael G Katz; Anthony S Fargnoli; Richard D Williams; Nury M Steuerwald; Alice Isidro; Anna V Ivanina; Inna M Sokolova; Charles R Bridges Journal: J Thorac Cardiovasc Surg Date: 2014-06-07 Impact factor: 5.209
Authors: Michael G Katz; Elizabeth Brandon-Warner; Anthony S Fargnoli; Richard D Williams; Andrew P Kendle; Roger J Hajjar; Laura W Schrum; Charles R Bridges Journal: J Thorac Cardiovasc Surg Date: 2015-11-25 Impact factor: 5.209